3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Pain
13
Pain, Postoperative
10
Neoplasms
8
Agnosia
8
Multiple Myeloma
7
Cancer Pain
5
Breast Neoplasms
5
Lung Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Trigger Finger Disorder
2
Lymphoma
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglion Cysts
2
De Quervain Disease
2
Chronic Pain
2
Burkitt Lymphoma
2
Acute Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Strabismus
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency
1
Interventions
Cyclophosphamide
220
Rituximab
189
fludarabine phosphate
169
fludarabine
102
Peripheral Blood Stem Cell Transplantation
100
Mycophenolic Acid
94
Whole-Body Irradiation
81
Tacrolimus
72
Filgrastim
69
Cyclosporine
67
Lenalidomide
66
ibrutinib
63
Busulfan
61
Melphalan
58
Antilymphocyte Serum
57
Radiotherapy
52
venetoclax
48
Etoposide
47
obinutuzumab
42
Bendamustine Hydrochloride
42
Alemtuzumab
41
Methotrexate
39
ofatumumab
28
sargramostim
27
Granulocyte Colony-Stimulating Factor
26
Cytarabine
26
Cord Blood Stem Cell Transplantation
26
acalabrutinib
25
Stem Cell Transplantation
24
Specimen Handling
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Acetaminophen
×
Clear all
NCT00840853
2025-07-09
MULTIPRAT
Baylor College of Medicine
Phase 1
Active not recruiting
68 enrolled